Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003
Published online before print May 1, 2003, doi: 10.1161/01.RES.0000074906.98021.55
A more recent version of this article appeared on June 13, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/11/1247    most recent
01.RES.0000074906.98021.55v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stepanovic, V.
Right arrow Articles by Schatteman, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stepanovic, V.
Right arrow Articles by Schatteman, G. C.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Diabetes
Related Collections
Right arrow Angiogenesis
Right arrow Animal models of human disease
Right arrow Type 2 diabetes
Right arrow Other Vascular biology

Submitted on August 14, 2002
Revised on April 3, 2003
Accepted on April 22, 2003

Leprdb Diabetic Mouse Bone Marrow Cells Inhibit Skin Wound Vascularization but Promote Wound Healing

Vesna Stepanovic ; Ola Awad ; Chunhua Jiao ; Martine Dunnwald ; and Gina C. Schatteman *

From the Departments of Exercise Science (V.S., O.A., C.J., G.C.S.) and Dermatology (M.D.), University of Iowa, Iowa City.

* To whom correspondence should be addressed. E-mail: gina-schatteman{at}uiowa.edu.

Bone marrow stem cells participate in tissue repair processes and may have roles in skin wound repair. Diabetes is characterized by delayed and poor wound healing, and type 1 diabetes seems to lead to stem cell dysfunction. Hence, stem cell dysfunction could contribute to poor healing, and stem cell-based therapies may be efficacious in diabetic wounds. We investigated the potential of exogenous stem cells to promote skin healing and possible effects of type 2 diabetes on stem cell function. Mouse bone marrow cells from nondiabetic and diabetic mice were enriched for putative stem cells and injected under skin wounds of nondiabetic or type 2 diabetic Leprdb mice. Using histology and morphometry, vascularization and healing in treated and untreated mice were analyzed. We anticipated a correlation between improved wound healing and vascularization, because therapies that increase tissue vascularization tend to enhance wound healing. Our data indicate that exogenous nondiabetic bone marrow-derived cells increase vascularization and improve wound healing in Leprdb mice but have little effect on nondiabetic controls. In contrast, Leprdb-derived marrow cells inhibit vascularization but promote wound healing in Leprdb mice. Thus, adult stem cell function may be impaired by type 2 diabetes; the ability to promote vascularization and wound healing are distinct functions of bone marrow cells; and neovascularization and wound healing may not be tightly coupled. Additionally, we observed little incorporation of injected cells into wound structures, suggesting that improved healing is mediated through mechanisms other than direct differentiation and incorporation of the cells.


Key words: bone marrow • stem cells • angiogenesis • wound healing • type 2 diabetes




This article has been cited by other articles:


Home page
Circ. Res.Home page
S. Dimmeler and A. Leri
Aging and Disease as Modifiers of Efficacy of Cell Therapy
Circ. Res., June 6, 2008; 102(11): 1319 - 1330.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Spinetti, N. Kraenkel, C. Emanueli, and P. Madeddu
Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies
Cardiovasc Res, May 1, 2008; 78(2): 265 - 273.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Caballero, N. Sengupta, A. Afzal, K.-H. Chang, S. Li Calzi, D. L. Guberski, T. S. Kern, and M. B. Grant
Ischemic Vascular Damage Can Be Repaired by Healthy, but Not Diabetic, Endothelial Progenitor Cells
Diabetes, April 1, 2007; 56(4): 960 - 967.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. C. Schatteman, M. Dunnwald, and C. Jiao
Biology of bone marrow-derived endothelial cell precursors
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H1 - H18.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
O. Awad, E. I. Dedkov, C. Jiao, S. Bloomer, R. J. Tomanek, and G. C. Schatteman
Differential Healing Activities of CD34+ and CD14+ Endothelial Cell Progenitors
Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 758 - 764.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Bruno, P. Chanez, G. Chiappara, L. Siena, S. Giammanco, M. Gjomarkaj, G. Bonsignore, J. Bousquet, and A. M. Vignola
Does leptin play a cytokine-like role within the airways of COPD patients?
Eur. Respir. J., September 1, 2005; 26(3): 398 - 405.
[Abstract] [Full Text] [PDF]


Home page
JRSMHome page
H T Hassan and M El-Sheemy
Adult bone-marrow stem cells and their potential in medicine
J R Soc Med, October 1, 2004; 97(10): 465 - 471.
[Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Jiao, S. Bronner, K. L. N. Mercer, D. D. Sheriff, G. C. Schatteman, and M. Dunnwald
Epidermal cells accelerate the restoration of the blood flow in diabetic ischemic limbs
J. Cell Sci., March 1, 2004; 117(7): 1055 - 1063.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Stephenson, J. Tunstead, A. Tsai, R. Gordon, S. Henderson, and H. M. Dansky
Neointimal Formation After Endovascular Arterial Injury Is Markedly Attenuated in db/db Mice
Arterioscler Thromb Vasc Biol, November 1, 2003; 23(11): 2027 - 2033.
[Abstract] [Full Text] [PDF]